{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:54:54Z","timestamp":1792029294169,"version":"4.4.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["555954864"],"award-info":[{"award-number":["555954864"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cholinergic system degeneration is a hallmark of Lewy body disease, including Parkinson\u2019s disease (PD) and dementia with Lewy bodies (DLB), but its involvement in prodromal stages, particularly regarding pedunculopontine-thalamic projections, remains unclear. This study investigated cholinergic pathway integrity in isolated REM sleep behaviour disorder (iRBD) and its relation to phenoconversion risk. We analyzed data from 146 iRBD patients and 102 controls from the Parkinson\u2019s Progression Markers Initiative using T1-weighted MRI for basal forebrain volume and diffusion-weighted imaging for three cholinergic pathways: lateral and medial nucleus basalis of Meynert (NBM)-cortical pathways and pedunculopontine nucleus (PPN)-thalamic pathways. Bayesian mixed models and Cox proportional hazards models assessed group differences, cognitive associations, and phenoconversion risk. Fractional anisotropy along PPN-thalamic pathways was reduced in iRBD, particularly in the left hemisphere. Within iRBD patients, medial NBM pathway integrity correlated with baseline cognitive performance. Reduced PPN-thalamic integrity predicted increased phenoconversion risk (hazard ratio=2.08). No group differences or associations with phenoconversion were found for NBM-cortical pathways or basal forebrain volume. These findings suggest that brainstem-thalamic cholinergic projections may be affected earlier than the basal forebrain system in Lewy body disease, potentially serving as a sensitive marker for phenoconversion risk in iRBD pending validation in longer follow-up studies.<\/jats:p>","DOI":"10.1038\/s41531-026-01311-0","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:25:38Z","timestamp":1772771138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pedunculopontine-thalamic cholinergic projections in rapid eye movement sleep behaviour disorder"],"prefix":"10.1038","volume":"12","author":[{"given":"Julia","family":"Schumacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Teipel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Storch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"1311_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jnc.14698","volume":"150","author":"L Walker","year":"2019","unstructured":"Walker, L., Stefanis, L. & Attems, J. Clinical and neuropathological differences between Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies\u2014current issues and future directions. J. Neurochem. 150, 467\u2013474 (2019).","journal-title":"J. Neurochem."},{"key":"1311_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"1311_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89, 88\u2013100 (2017).","journal-title":"Neurology"},{"key":"1311_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M. & Morris, J. G. L. The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years: twenty year Sydney Parkinson\u2019s Study. Mov. Disord. 23, 837\u2013844 (2008).","journal-title":"Mov. Disord."},{"key":"1311_CR5","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1093\/brain\/awz111","volume":"142","author":"SM Fereshtehnejad","year":"2019","unstructured":"Fereshtehnejad, S. M. et al. Evolution of prodromal Parkinson\u2019s disease and dementia with Lewy bodies: a prospective study. Brain 142, 2051\u20132067 (2019).","journal-title":"Brain"},{"key":"1311_CR6","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/mds.27670","volume":"34","author":"RB Postuma","year":"2019","unstructured":"Postuma, R. B. & Berg, D. Prodromal Parkinson\u2019s disease: the decade past, the decade to come. Mov. Disord. 34, 665\u2013675 (2019).","journal-title":"Mov. Disord."},{"key":"1311_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-018-0016-5","volume":"4","author":"Y Dauvilliers","year":"2018","unstructured":"Dauvilliers, Y. et al. REM sleep behaviour disorder. Nat. Rev. Dis. Prim. 4, 19 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1311_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1474-4422(13)70056-5","volume":"12","author":"A Iranzo","year":"2013","unstructured":"Iranzo, A. et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol. 12, 443\u2013453 (2013).","journal-title":"Lancet Neurol."},{"key":"1311_CR9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/brain\/awz030","volume":"142","author":"RB Postuma","year":"2019","unstructured":"Postuma, R. B. et al. Risk and predictors of dementia and Parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain 142, 744\u2013759 (2019).","journal-title":"Brain"},{"key":"1311_CR10","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/ana.24385","volume":"77","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann. Neurol. 77, 830\u2013839 (2015).","journal-title":"Ann. Neurol."},{"key":"1311_CR11","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.5665\/sleep.6102","volume":"39","author":"F Sixel-D\u00f6ring","year":"2016","unstructured":"Sixel-D\u00f6ring, F., Zimmermann, J., Wegener, A., Mollenhauer, B. & Trenkwalder, C. The evolution of rem sleep behavior disorder in early Parkinson disease. Sleep 39, 1737\u20131742 (2016).","journal-title":"Sleep"},{"key":"1311_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106101","volume":"122","author":"J Horsager","year":"2024","unstructured":"Horsager, J. & Borghammer, P. Brain-first vs. body-first Parkinson\u2019s disease: an update on recent evidence. Park. Relat. Disord. 122, 106101 (2024).","journal-title":"Park. Relat. Disord."},{"key":"1311_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13670-018-0234-4","volume":"7","author":"NI Bohnen","year":"2018","unstructured":"Bohnen, N. I., Grothe, M. J., Ray, N. J., M\u00fcller, M. L. T. M. & Teipel, S. J. Recent advances in cholinergic imaging and cognitive decline\u2014revisiting the cholinergic hypothesis of dementia. Curr. Geri Rep. 7, 1\u201311 (2018).","journal-title":"Curr. Geri Rep."},{"key":"1311_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1212\/WNL.0b013e3181d55f61","volume":"74","author":"JC Klein","year":"2010","unstructured":"Klein, J. C. et al. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology 74, 885\u2013892 (2010).","journal-title":"Neurology"},{"key":"1311_CR15","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1136\/jnnp-2019-320450","volume":"90","author":"MJ Barrett","year":"2019","unstructured":"Barrett, M. J. et al. Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease. J. Neurol. Neurosurg. Psychiatry 90, 1251\u20131256 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1311_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2021.102604","volume":"30","author":"J Schumacher","year":"2021","unstructured":"Schumacher, J. et al. In vivo nucleus basalis of Meynert degeneration in mild cognitive impairment with Lewy bodies. NeuroImage Clin. 30, 102604 (2021).","journal-title":"NeuroImage Clin."},{"key":"1311_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/brain\/awx310","volume":"141","author":"NJ Ray","year":"2018","unstructured":"Ray, N. J. et al. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson\u2019s disease. Brain 141, 165\u2013176 (2018).","journal-title":"Brain"},{"key":"1311_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/brain\/awaf168","volume":"149","author":"T Eisenstein","year":"2025","unstructured":"Eisenstein, T. et al. Cholinergic degeneration in prodromal and early Parkinsonas: a link to present and future disease states. Brain 149, 226\u2013237 (2025).","journal-title":"Brain"},{"key":"1311_CR19","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1093\/brain\/awaf196","volume":"148","author":"R Kim","year":"2025","unstructured":"Kim, R. et al. Cholinergic basal forebrain degeneration in isolated REM sleep behaviour disorder. Brain 148, 4084\u20134097 (2025).","journal-title":"Brain"},{"key":"1311_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.sleep.2023.06.013","volume":"109","author":"A Yang","year":"2023","unstructured":"Yang, A. & Li, G. Nucleus basalis of Meynert predicts cognitive changes in isolated REM sleep behavior disorder. Sleep. Med. 109, 11\u201317 (2023).","journal-title":"Sleep. Med."},{"key":"1311_CR21","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/brain\/awab372","volume":"145","author":"J Schumacher","year":"2022","unstructured":"Schumacher, J. et al. Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer\u2019s disease. Brain 145, 1773\u20131784 (2022).","journal-title":"Brain"},{"key":"1311_CR22","doi-asserted-by":"publisher","first-page":"106243","DOI":"10.1016\/j.nbd.2023.106243","volume":"185","author":"RA Crockett","year":"2023","unstructured":"Crockett, R. A. No laughing white matter: reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairment. Neurobiol. Dis 185, 106243 (2023).","journal-title":"Neurobiol. Dis"},{"key":"1311_CR23","doi-asserted-by":"publisher","unstructured":"Eisenstein, T. et al. Cholinergic white matter pathways integrity in prodromal and early manifest Lewy body disease. Brain Communications 7, https:\/\/doi.org\/10.1093\/braincomms\/fcaf421 (2025).","DOI":"10.1093\/braincomms\/fcaf421"},{"key":"1311_CR24","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s00415-014-7439-z","volume":"261","author":"MJ Grothe","year":"2014","unstructured":"Grothe, M. J. et al. Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer\u2019s disease dementia. J. Neurol. 261, 1939\u20131948 (2014).","journal-title":"J. Neurol."},{"key":"1311_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13195-025-01678-x","volume":"17","author":"J Schumacher","year":"2025","unstructured":"Schumacher, J., Teipel, S. & Storch, A. Association of Alzheimer\u2019s and Lewy body disease pathology with basal forebrain volume and cognitive impairment. Alz Res. Ther. 17, 28 (2025).","journal-title":"Alz Res. Ther."},{"key":"1311_CR26","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1093\/brain\/awac385","volume":"146","author":"M Nemy","year":"2023","unstructured":"Nemy, M. et al. Cholinergic white matter pathways along the Alzheimer\u2019s disease continuum. Brain 146, 2075\u20132088 (2023).","journal-title":"Brain"},{"key":"1311_CR27","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.neuroimage.2007.05.050","volume":"37","author":"BR Aravamuthan","year":"2007","unstructured":"Aravamuthan, B. R., Muthusamy, K. A., Stein, J. F., Aziz, T. Z. & Johansen-Berg, H. Topography of cortical and subcortical connections of the human pedunculopontine and subthalamic nuclei. NeuroImage 37, 694\u2013705 (2007).","journal-title":"NeuroImage"},{"key":"1311_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/cne.902140206","volume":"214","author":"MM Mesulam","year":"1983","unstructured":"Mesulam, M. M., Mufson, E. J., Levey, A. I. & Wainer, B. H. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey. J. Comp. Neurol. 214, 170\u2013197 (1983).","journal-title":"J. Comp. Neurol."},{"key":"1311_CR29","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1002\/alz.13034","volume":"19","author":"J Schumacher","year":"2023","unstructured":"Schumacher, J. et al. Free water imaging of the cholinergic system in dementia with Lewy bodies and Alzheimer\u2019s disease. Alzheimer\u2019s. Dement. 19, 4549\u20134563 (2023).","journal-title":"Alzheimer\u2019s. Dement."},{"key":"1311_CR30","doi-asserted-by":"publisher","first-page":"S351","DOI":"10.1002\/mds.21683","volume":"22","author":"PT Francis","year":"2007","unstructured":"Francis, P. T. & Perry, E. K. Cholinergic and other neurotransmitter mechanisms in Parkinson\u2019s disease, Parkinson\u2019s disease dementia, and dementia with Lewy bodies. Mov. Disord. 22, S351\u2013S357 (2007).","journal-title":"Mov. Disord."},{"key":"1311_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neulet.2012.02.083","volume":"514","author":"V Kotagal","year":"2012","unstructured":"Kotagal, V., M\u00fcller, M. L. T. M., Kaufer, D. I., Koeppe, R. A. & Bohnen, N. I. Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders. Neurosci. Lett. 514, 169\u2013172 (2012).","journal-title":"Neurosci. Lett."},{"key":"1311_CR32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ana.22691","volume":"71","author":"V Kotagal","year":"2012","unstructured":"Kotagal, V. et al. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann. Neurol. 71, 560\u2013568 (2012).","journal-title":"Ann. Neurol."},{"key":"1311_CR33","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1176\/appi.neuropsych.19070165","volume":"32","author":"P Kanel","year":"2020","unstructured":"Kanel, P. et al. Topography of cholinergic changes in dementia with Lewy bodies and key neural network hubs. J. Neuropsychiatry Clin. Neurosci. 32, 370\u2013375 (2020).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"1311_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/mds.24007","volume":"27","author":"A Van Der Hoorn","year":"2012","unstructured":"Van Der Hoorn, A., Burger, H., Leenders, K. L. & De Jong, B. M. Handedness correlates with the dominant Parkinson side: a systematic review and meta-analysis. Mov. Disord. 27, 206\u2013210 (2012).","journal-title":"Mov. Disord."},{"key":"1311_CR35","doi-asserted-by":"publisher","first-page":"e1605","DOI":"10.1212\/WNL.0000000000009246","volume":"94","author":"A Iranzo","year":"2020","unstructured":"Iranzo, A. et al. Left-hemispheric predominance of nigrostriatal deficit in isolated REM sleep behavior disorder. Neurology 94, e1605\u2013e1613 (2020).","journal-title":"Neurology"},{"key":"1311_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.parkreldis.2022.01.015","volume":"95","author":"T Miyamoto","year":"2022","unstructured":"Miyamoto, T. et al. Striatal dopamine transporter degeneration in right-handed REM sleep behavior disorder patients progresses faster in the left hemisphere. Park. Relat. Disord. 95, 107\u2013112 (2022).","journal-title":"Park. Relat. Disord."},{"key":"1311_CR37","doi-asserted-by":"publisher","first-page":"e14584","DOI":"10.1002\/alz.14584","volume":"21","author":"KA Woo","year":"2025","unstructured":"Woo, K. A. et al. Cholinergic degeneration and early cognitive signs in prodromal Lewy body dementia. Alzheimers Dement. 21, e14584 (2025).","journal-title":"Alzheimers Dement."},{"key":"1311_CR38","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/mdc3.70242","volume":"13","author":"L Churchill","year":"2026","unstructured":"Churchill, L. et al. Basal forebrain volume predicts disease conversion in prodromal synucleinopathy. Mov. Disord. Clin. Pract 13, 198\u2013207 (2026).","journal-title":"Mov. Disord. Clin. Pract"},{"key":"1311_CR39","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/WNL.0b013e3181fc29c9","volume":"75","author":"JC Dalrymple-Alford","year":"2010","unstructured":"Dalrymple-Alford, J. C. et al. The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 75, 1717\u20131725 (2010).","journal-title":"Neurology"},{"key":"1311_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2024.123283","volume":"466","author":"E Fiorenzato","year":"2024","unstructured":"Fiorenzato, E. et al. Optimal MMSE and MoCA cutoffs for cognitive diagnoses in Parkinson\u2019s disease: a data-driven decision tree model. J. Neurol. Sci. 466, 123283 (2024).","journal-title":"J. Neurol. Sci."},{"key":"1311_CR41","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/mds.29570","volume":"38","author":"MGA Van Cauwenberge","year":"2023","unstructured":"Van Cauwenberge, M. G. A. et al. Mild motor signs in healthy aging are associated with lower synaptic density in the brain. Mov. Disord. 38, 1786\u20131794 (2023).","journal-title":"Mov. Disord."},{"key":"1311_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105753","volume":"117","author":"S Joza","year":"2025","unstructured":"Joza, S. et al. Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorder. eBioMedicine 117, 105753 (2025).","journal-title":"eBioMedicine"},{"key":"1311_CR43","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1093\/brain\/awaf003","volume":"148","author":"A Delva","year":"2025","unstructured":"Delva, A. et al. Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder. Brain 148, 2049\u20132059 (2025).","journal-title":"Brain"},{"key":"1311_CR44","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neuroimage.2017.08.047","volume":"161","author":"JP Fortin","year":"2017","unstructured":"Fortin, J. P. et al. Harmonization of multi-site diffusion tensor imaging data. NeuroImage 161, 149\u2013170 (2017).","journal-title":"NeuroImage"},{"key":"1311_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2023.120125","volume":"274","author":"F Hu","year":"2023","unstructured":"Hu, F. et al. Image harmonization: a review of statistical and deep learning methods for removing batch effects and evaluation metrics for effective harmonization. NeuroImage 274, 120125 (2023).","journal-title":"NeuroImage"},{"key":"1311_CR46","doi-asserted-by":"crossref","unstructured":"Ray N. J. et al. Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson\u2019s disease. Brain 146, 1053\u20131064 (2023).","DOI":"10.1093\/brain\/awac127"},{"key":"1311_CR47","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/mds.28051","volume":"35","author":"CE Craig","year":"2020","unstructured":"Craig, C. E. et al. Pedunculopontine nucleus microstructure predicts postural and gait symptoms in Parkinson\u2019s disease. Mov. Disord. 35, 1199\u20131207 (2020).","journal-title":"Mov. Disord."},{"key":"1311_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neuron.2017.02.027","volume":"94","author":"J Mena-Segovia","year":"2017","unstructured":"Mena-Segovia, J. & Bolam, J. P. Rethinking the pedunculopontine nucleus: from cellular organization to function. Neuron 94, 7\u201318 (2017).","journal-title":"Neuron"},{"key":"1311_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0006-8993(85)90527-X","volume":"329","author":"MV Sofroniew","year":"1985","unstructured":"Sofroniew, M. V., Priestley, J. V., Consolazione, A., Eckenstein, F. & Cuello, A. C. Cholinergic projections from the midbrain and pons to the thalamus in the rat, identified by combined retrograde tracing and choline acetyltransferase immunohistochemistry. Brain Res. 329, 213\u2013223 (1985).","journal-title":"Brain Res."},{"key":"1311_CR50","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1093\/brain\/121.12.2249","volume":"121","author":"N Selden","year":"1998","unstructured":"Selden, N. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain 121, 2249\u20132257 (1998).","journal-title":"Brain"},{"key":"1311_CR51","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3233\/JAD-132345","volume":"40","author":"I Kilimann","year":"2014","unstructured":"Kilimann, I. et al. Subregional basal forebrain atrophy in alzheimer\u2019s disease: a multicenter study. J. Alzheimers Dis. 40, 687\u2013700 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"1311_CR52","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/hbm.24417","volume":"40","author":"HCJ Fritz","year":"2019","unstructured":"Fritz, H. C. J. et al. The corticotopic organization of the human basal forebrain as revealed by regionally selective functional connectivity profiles. Hum. Brain Mapp. 40, 868\u2013878 (2019).","journal-title":"Hum. Brain Mapp."},{"key":"1311_CR53","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1093\/brain\/awh589","volume":"128","author":"SJ Teipel","year":"2005","unstructured":"Teipel, S. J. et al. Measurement of basal forebrain atrophy in alzheimer\u2019s disease using MRI. Brain 128, 2626\u20132644 (2005).","journal-title":"Brain"},{"key":"1311_CR54","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.neuroimage.2008.05.055","volume":"42","author":"L Zaborszky","year":"2008","unstructured":"Zaborszky, L. et al. Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain. NeuroImage 42, 1127\u20131141 (2008).","journal-title":"NeuroImage"},{"key":"1311_CR55","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.mri.2019.05.008","volume":"64","author":"KG Schilling","year":"2019","unstructured":"Schilling, K. G. et al. Synthesized b0 for diffusion distortion correction (Synb0-DisCo). Magn. Reson. Imaging 64, 62\u201370 (2019).","journal-title":"Magn. Reson. Imaging"},{"key":"1311_CR56","doi-asserted-by":"crossref","unstructured":"Schilling K. G. et al. Distortion correction of diffusion weighted MRI without reverse phase-encoding scans or field-maps. PLoS ONE 15, e0236418 (2020).","DOI":"10.1371\/journal.pone.0236418"},{"key":"1311_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2022.119474","volume":"260","author":"A Hoopes","year":"2022","unstructured":"Hoopes, A., Mora, J. S., Dalca, A. V., Fischl, B. & Hoffmann, M. SynthStrip: skull-stripping for any brain image. NeuroImage 260, 119474 (2022).","journal-title":"NeuroImage"},{"key":"1311_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.116607","volume":"211","author":"M Nemy","year":"2020","unstructured":"Nemy, M. et al. Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert. NeuroImage 211, 116607 (2020).","journal-title":"NeuroImage"},{"key":"1311_CR59","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/0006-8993(87)90783-9","volume":"406","author":"CA Kitt","year":"1987","unstructured":"Kitt, C. A., Mitchell, S. J., DeLong, M. R., Wainer, B. H. & Price, D. L. Fiber pathways of basal forebrain cholinergic neurons in monkeys. Brain Res. 406, 192\u2013206 (1987).","journal-title":"Brain Res."},{"key":"1311_CR60","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.neuroimage.2017.04.070","volume":"170","author":"M Bianciardi","year":"2018","unstructured":"Bianciardi, M. et al. A probabilistic template of human mesopontine tegmental nuclei from in vivo 7 T MRI. NeuroImage 170, 222\u2013230 (2018).","journal-title":"NeuroImage"},{"key":"1311_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2019.116189","volume":"206","author":"ET Rolls","year":"2020","unstructured":"Rolls, E. T., Huang, C. C., Lin, C. P., Feng, J. & Joliot, M. Automated anatomical labelling atlas 3. NeuroImage 206, 116189 (2020).","journal-title":"NeuroImage"},{"key":"1311_CR62","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuroimage.2013.05.041","volume":"80","author":"DC Van Essen","year":"2013","unstructured":"Van Essen, D. C. et al. The WU-Minn human connectome project: an overview. NeuroImage 80, 62\u201379 (2013).","journal-title":"NeuroImage"},{"key":"1311_CR63","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neuroimage.2013.05.057","volume":"80","author":"SN Sotiropoulos","year":"2013","unstructured":"Sotiropoulos, S. N. et al. Advances in diffusion MRI acquisition and processing in the Human Connectome Project. NeuroImage 80, 125\u2013143 (2013).","journal-title":"NeuroImage"},{"key":"1311_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynirp.2022.100136","volume":"2","author":"S Richter","year":"2022","unstructured":"Richter, S. et al. Validation of cross-sectional and longitudinal ComBat harmonization methods for magnetic resonance imaging data on a travelling subject cohort. Neuroimage Rep. 2, 100136 (2022).","journal-title":"Neuroimage Rep."},{"key":"1311_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43586-020-00001-2","volume":"1","author":"R Van De Schoot","year":"2021","unstructured":"Van De Schoot, R. et al. Bayesian statistics and modelling. Nat. Rev. Methods Prim. 1, 1 (2021).","journal-title":"Nat. Rev. Methods Prim."},{"key":"1311_CR66","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/alz.12374","volume":"17","author":"AGM Temp","year":"2021","unstructured":"Temp, A. G. M. et al. How Bayesian statistics may help answer some of the controversial questions in clinical research on Alzheimer\u2019s disease. Alzheimers Dement. 17, 917\u2013919 (2021).","journal-title":"Alzheimers Dement."},{"key":"1311_CR67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3758\/s13423-017-1343-3","volume":"25","author":"EJ Wagenmakers","year":"2018","unstructured":"Wagenmakers, E. J. et al. Bayesian inference for psychology. Part I: Theoretical advantages and practical ramifications. Psychon. Bull. Rev. 25, 35\u201357 (2018).","journal-title":"Psychon. Bull. Rev."},{"key":"1311_CR68","doi-asserted-by":"publisher","unstructured":"B\u00fcrkner P. C. brms: An R package for Bayesian multilevel models using Stan. J. Stat. Soft. 80, https:\/\/doi.org\/10.18637\/jss.v080.i01 (2017).","DOI":"10.18637\/jss.v080.i01"},{"key":"1311_CR69","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jmp.2012.08.001","volume":"56","author":"JN Rouder","year":"2012","unstructured":"Rouder, J. N., Morey, R. D., Speckman, P. L. & Province, J. M. Default Bayes factors for ANOVA designs. J. Math. Psychol. 56, 356\u2013374 (2012).","journal-title":"J. Math. Psychol."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01311-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01311-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01311-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:02:22Z","timestamp":1773680542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01311-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1311"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01311-0","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}